Sr. Director – Immunology Translational Medicine at Eli Lilly and Company

Indianapolis, Indiana, United States

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceuticals, HealthcareIndustries

Requirements

Ph.D. or M.D. in Immunology or related life science field
At least 6 or more years of relevant pharmaceutical, biotech industry, or drug development experience, supporting clinical programs in the areas of rheumatology, respiratory, and/or gastroenterology with Translational Immunology assays and strategies
Deep understanding of the drug discovery process
Experience working independently and in a matrixed environment with demonstrated ability to prioritize work for team, and meeting ambitious goals and timelines
Passion for innovation and leadership

Responsibilities

Define and execute Translational strategies for multiple programs in parallel to enable Lilly’s immunology portfolio
Play a key role in all Translational Immunology activities through active collaboration with program teams at various stages of discovery and clinical development
Establish and maintain a laboratory that leads and/or supports Translational Immunology aspects of programs in the Lilly pipeline and prioritize work
Initiate and drive publication strategy of biomarker research findings for disclosure at conferences and in journals
Protocol and regulatory support for the biomarker portion of Immunology clinical programs
Identify internal and external resources to enable biomarker strategies, in conjunction with operations and clinical teams
Support discovery efforts by identifying and enabling novel targets/pathways through collection and analysis of human bio-samples (bedside-to-bench)
Represent Lilly Translational Immunology in collaborations with external partners and help in establishing new partnerships with academic or biotech/pharma partners
Maintain vigilance and strategically incorporate novel translational tools, including developments in Precision Medicine, novel approaches or technologies, companion diagnostics, imaging techniques, etc
Provide strategic input on future Lilly Immunology investment prospects
Actively coach, mentor, and develop other scientists at Lilly

Skills

Immunology

Translational Medicine

Biomarkers

Autoimmunity

Clinical Trials

Drug Development

Leadership

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Indianapolis, IndianaHeadquarters

1876Year Founded

$1,180.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.

Potential construction delays in Indiana could affect GLP-1 drug production timelines.

Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.

Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.

FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.

Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.

Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI

Try Jobo Free